Literature DB >> 23479396

Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.

M Hedman1, T Björk-Eriksson, O Brodin, I Toma-Dasu.   

Abstract

OBJECTIVE: The aim of this study was to compare patient-specific radiobiological parameters with population averages in predicting the clinical outcome after radiotherapy (RT) using a tumour control probability (TCP) model based on the biological effective dose (BED).
METHODS: A previously published study of 46 head and neck carcinomas with individually identified radiobiological parameters, radiosensitivity and potential doubling time (Tpot), and known tumour size was investigated. These patients had all been treated with external beam RT, and the majority had also received brachytherapy. The TCP for each individual based on the BED using patient-specific radiobiological parameters was compared with the TCP based on the BED using average radiobiological parameters (α=0.3 Gy(-1), Tpot=3 days).
RESULTS: 43 patients remained in the final analysis. There was only a weak trend for increasing local tumour control with increasing BED in both groups. However, when the TCP was calculated, the use of patient-specific parameters was better for identifying local control correctly. The sensitivity and specificity for tumour-specific parameters were 63% and 80%, respectively. The corresponding values for population-based averages were 0% and 91%, respectively. The positive predictive value was 92% when tumour-specific parameters were used compared with 0% for population-based averages. A receiver operating characteristic curve confirmed the superiority of patient-specific parameters over population averages in predicting local control.
CONCLUSION: Individual radiobiological parameters are better than population-derived averages when used in a mathematical model to predict TCP after curative RT in head and neck carcinomas. ADVANCES IN KNOWLEDGE: TCP based on individual radiobiological parameters is better than TCP based on population-based averages for identifying local control correctly.

Entities:  

Mesh:

Year:  2013        PMID: 23479396      PMCID: PMC3635803          DOI: 10.1259/bjr.20130015

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.

Authors:  T Björk-Eriksson; C West; E Karlsson; C Mercke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-01       Impact factor: 7.038

Review 2.  Cell production rates in human tissues and tumours and their significance. Part II: clinical data.

Authors:  D A Rew; G D Wilson
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

Review 3.  Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

Authors:  G W Barendsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

4.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

Authors:  R G Dale
Journal:  Br J Radiol       Date:  1985-06       Impact factor: 3.039

Review 5.  The role of biologically effective dose (BED) in clinical oncology.

Authors:  B Jones; R G Dale; C Deehan; K I Hopkins; D A Morgan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

6.  Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

Authors:  C Petersen; D Zips; M Krause; K Schöne; W Eicheler; C Hoinkis; H D Thames; M Baumann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

7.  Cell and environment interactions in tumor microregions: the multicell spheroid model.

Authors:  R M Sutherland
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

8.  Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients.

Authors:  R R Weichselbaum; W Dahlberg; M Beckett; T Karrison; D Miller; J Clark; T J Ervin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

10.  Self-regulation of growth in three dimensions.

Authors:  J Folkman; M Hochberg
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Towards multidimensional radiotherapy: key challenges for treatment individualisation.

Authors:  Iuliana Toma-Dasu; Alexandru Dasu
Journal:  Comput Math Methods Med       Date:  2015-03-05       Impact factor: 2.238

2.  Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.

Authors:  Changran Geng; Harald Paganetti; Clemens Grassberger
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.